NCT00004368Unknown1 期
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
National Center for Research Resources (NCRR)0 个研究点目标入组 15 人开始时间: 1990年5月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 15
研究概览
简要总结
OBJECTIVES:
I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
详细描述
PROTOCOL OUTLINE: Patients receive colchicine orally twice daily for 24 months. After the first month, the dose of colchicine will increase and remain at that dose for the duration of study.
Patients are evaluated every 6 months during study.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 0 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Advanced hepatic fibrosis or cirrhosis in children
- •Not pregnant
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative TreatmentHepatocellular Carcinoma Stage IIIBCholangiocarcinoma, IntrahepaticHepatocellular Carcinoma Stage IVWith Hepatocellular Carcinoma CholangiocarcinomaNCT04264260Kaohsiung Medical University Chung-Ho Memorial Hospital42
已完成
2 期
Effect of Colchicine for the Palliative Management of Hepatocellular CarcinomaMetastasisInvasionHepatocellular CarcinomaNCT01935700Kaohsiung Medical University Chung-Ho Memorial Hospital15
招募中
3 期
Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)Coronary Artery DiseaseNCT05739929Helwan University400
已完成
4 期
Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of AllopurinolIntercritical GoutNCT01451645Regeneron Pharmaceuticals82
招募中
3 期
Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctioIRCT20190601043780N1Mashhad University of Medical Sciences140